期刊文献+

卵巢上皮性癌保留生育功能手术的研究进展 被引量:13

原文传递
导出
摘要 在女性生殖系统恶性肿瘤中,卵巢恶性肿瘤的发病率仅次于子宫颈癌和子宫内膜癌,但病死率却位居首位.卵巢上皮性癌(卵巢癌)占卵巢恶性肿瘤的80%左右,早期卵巢癌患者的5年生存率可达到80%~ 90%.随着医学的发展,对于年轻的早期卵巢癌患者,已逐渐离开传统的根治性手术治疗的模式,而是在对患者预后无明显影响的前提下,更多地关注患者术后生育功能等生命质量问题,越来越体现个体化的治疗原则.卵巢癌与其他病理类型的卵巢恶性肿瘤在诊治和预后上均差异较大,本文将着重对卵巢癌保留生育功能手术的适应证、手术范围、预后、妊娠结局、术后化疗选择、卵巢功能保护等方面的最新进展进行综述.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2014年第8期638-640,共3页 Chinese Journal of Obstetrics and Gynecology
  • 相关文献

参考文献1

二级参考文献20

  • 1Borgfeldt C, Iosif C, M~sb~ick A. Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer. Eur J Obstet Gynecol Reprod Biol 2007; 134:110-114.
  • 2Kesic V, Rodolakis A, Denschlag D, Schneider A, Morice P, Amant F, et al. Fertility preserving management in gynecologic cancer patients: the need for centralization. Int J Gynecol Cancer 2010; 20: 1613-1619.
  • 3Kesic V. Fertility after the treatment of gynecologic tumors. Recent Results Cancer Res 2008; 178: 79-95.
  • 4Rodriguez-Wallberg KA, Oktay K. Options on fertility preservation in female cancer patients. Cancer Treat Rev 2012; 38: 354-361.
  • 5Blumenfeld Z, Avivi I, Linn S, Epelbaurn R, Ben-Shahar M, Haim N. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. Hum Reprod 1996; 11: 1620-1626.
  • 6Pereyra Pacheco B, Mendez Ribas JM, Milone G, Fernandez I, Kvicala R, Mila T, et al. Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report. Gynecol Oncol 2001; 81 : 391-397.
  • 7Kreuser ED, Hetzel WD, Billia DO, Thiel E. Gonadal toxicity following cancer therapy in adults: significance, diagnosis, prevention and treatment. Cancer Treat Rev 1990; 17: 169-175.
  • 8Badawy A, Elnashar A, El-Ashry M, Shahat M. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril 2009; 91: 594-697.
  • 9Stroud JS, Mutch D, Rader J, Powell M, Thaker PH, Grigsby PW. Effects of cancer treatment on ovarian function. Fertil Steril 2009; 92. 417-427.
  • 10Kim SS. Fertility preservation in female cancer patients: current developments and future directions. Fertil Steril 2006; 85: 1-11.

共引文献9

同被引文献88

  • 1黄永文,李孟达,刘富元,李玉洁,李艳芳.卵巢恶性生殖细胞肿瘤手术方式的探讨[J].实用癌症杂志,2005,20(1):75-77. 被引量:11
  • 2段微,范逢晓.保留生育功能手术对卵巢交界性肿瘤临床治疗效果的影响[J].中国实用妇科与产科杂志,2006,22(6):449-450. 被引量:11
  • 3Pietzner K,Richter R,Chekerov R eta|. Bevacizumab in heavily pre-treated and Platinum resistant ovarian Cancer:a retro- spective study of the North-Eastern Ger- man Society of Gynaecologic Oncology (NOGGO)Ovarian Cancer Study Group[J]. Anticancer Res, 2011,31 (8) : 2679-2682.
  • 4Duska LR,Chang YC,Flynn CE et al. Epithelial ovarian carcinoma in the repro- ductive age group [J]. Cancer,85 (12): 2623-2629.
  • 5Wright JD,Shah M,Mathew L et al. Fer- tility preservation in young women with epithelial ovarian Cancer [J]. Cancer, 2009,115(18) :4118-4126.
  • 6BenjaminI, MorganMA, RubinSC.Occuh bilateral involvement instage I epithelialovariancancer [J].Gynecol Oncol, 1999,72 (3) :288-291.
  • 7Anchezar JP,Sardi J,Soderini A.Longterm follow up results of fertility sparing surgery in patients with epithelial ovariancancer [J]. J Surg 0ncol,2009,100 (1): 55-58.
  • 8SatohT,HataeM,WatanabeY et al. Out- comes of fertility sparing surgery for stage I epithelial ovarian caneer:a proposal for patient selection [J]. J Clin Oncol, 2010,28 : 1727-1732.
  • 9Zhang.l,GrifoJA,Del PrioreG. Gestationalcarrier pregnancy with oocytes obtained during surgery forstage III covarian cancer after controlled ovarian stimulation [J]. Fertil Steril, 2005,83 (5) : 1547-1549.
  • 10Cheng X,Cheng B,Wan X,et al.Outcomes of conservative surgery in early epithelial ovarian carcinoma.Eur J Gynaecol Oncol,2011,33(1):93-95.

引证文献13

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部